{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:20:43Z","timestamp":1782976843700,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006087","name":"Direcci\u00f3n General de Asuntos del Personal Acad\u00e9mico, Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","award":["IN201022 and IN201425"],"award-info":[{"award-number":["IN201022 and IN201425"]}],"id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Type 2 diabetes (T2D), a growing global health concern, is often exacerbated by obesity and is linked to severe complications. Serpins, a superfamily of serine protease inhibitors, that includes SerpinA3 in humans and its homolog SerpinA3k in mice. SerpinA3k regulates angiogenesis, reactive oxygen species (ROS) production, inflammation, and fibrosis particularly in the context of experimental ocular injury. Furthermore, we have previously demonstrated that urinary SerpinA3 serves as an early biomarker of kidney damage, including diabetic nephropathy; however, its functional role in renal damage, obesity, and T2D remains largely unexplored. This study explored the impact of SerpinA3k deficiency on obesity and T2D and its associated metabolic dysfunctions. Wild-type (WT,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200927) and SerpinA3k knockout (KO\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200926) male mice were randomly assigned to three groups: standard chow diet (SD), high-fat diet (HFD) to induce obesity, and HFD combined with streptozotocin to induce T2D (D2). All the mice were followed and studied after 27 weeks. As expected, WT\u2009+\u2009D2 mice presented severe hyperglycemia, hyperinsulinemia, increased fat tissue, visceral adipocyte hypertrophy, and renal hyperfiltration. In sharp contrast, diabetic SerpinA3k-deficient mice were protected against these alterations, displaying improved glycemic control, greater pancreatic insulin content, reduced insulin resistance, and favorable adipocyte size remodeling characterized by a lower proportion of medium and large adipocytes. Additionally, these mice showed preserved lipolytic function, and attenuated renal hyperfiltration. Our findings indicate that targeting SerpinA3k mitigates hyperglycemia and insulin resistance, preserves adipose tissue functionality, and potentially prevents metabolic complications. These results highlight SerpinA3k as a promising therapeutic target for T2D.\n                  <\/jats:p>","DOI":"10.1007\/s00018-025-05922-3","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T05:01:05Z","timestamp":1764651665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SerpinA3k Deficiency Ameliorates Experimental type 2 Diabetes"],"prefix":"10.1007","volume":"82","author":[{"given":"Isaac","family":"Gonz\u00e1lez-Soria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmeralda","family":"Palacios-Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulce","family":"G\u00f3mez-Trujillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Barrag\u00e1n-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel D.","family":"Soto-Valadez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Mart\u00ednez-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Oliva-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"P\u00e9rez-Villalva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"L\u00f3pez-Griego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"D\u00edaz-Villase\u00f1or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3153-9151","authenticated-orcid":false,"given":"Norma A.","family":"Bobadilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"5922_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109083","volume":"183","author":"GD Ogle","year":"2022","unstructured":"Ogle GD, James S, Dabelea D, Pihoker C, Svennson J, Maniam J, Klatman EL, Patterson CC (2022) Global estimates of incidence of type 1 diabetes in children and adolescents: results from the International Diabetes Federation Atlas, 10th edition. Diabetes Res Clin Pract 183:109083. https:\/\/doi.org\/10.1016\/j.diabres.2021.109083","journal-title":"Diabetes Res Clin Pract"},{"key":"5922_CR2","doi-asserted-by":"publisher","first-page":"s238","DOI":"10.21149\/14809","volume":"65","author":"I Campos-Nonato","year":"2023","unstructured":"Campos-Nonato I, Galvan-Valencia O, Hernandez-Barrera L, Oviedo-Solis C, Barquera S (2023) Prevalencia de obesidad y factores de riesgo asociados en adultos mexicanos: resultados de la Ensanut 2022. Salud Publica Mex 65:s238\u2013s247. https:\/\/doi.org\/10.21149\/14809","journal-title":"Salud Publica Mex"},{"key":"5922_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01400-z","volume":"8","author":"Y Li","year":"2023","unstructured":"Li Y, Liu Y, Liu S, Gao M, Wang W, Chen K, Huang L, Liu Y (2023) Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal Transduct Target Ther 8:152. https:\/\/doi.org\/10.1038\/s41392-023-01400-z","journal-title":"Signal Transduct Target Ther"},{"key":"5922_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035285","volume":"102","author":"Y Lu","year":"2023","unstructured":"Lu Y, Wang W, Liu J, Xie M, Liu Q, Li S (2023) Vascular complications of diabetes: a narrative review. Medicine (Baltimore) 102:e35285. https:\/\/doi.org\/10.1097\/MD.0000000000035285","journal-title":"Medicine (Baltimore)"},{"key":"5922_CR5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI165654","author":"S Mohandes","year":"2023","unstructured":"Mohandes S, Doke T, Hu H, Mukhi D, Dhillon P, Susztak K (2023) Molecular pathways that drive diabetic kidney disease. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI165654","journal-title":"J Clin Invest"},{"key":"5922_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","volume":"102","author":"KR Tuttle","year":"2022","unstructured":"Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, Uribarri J (2022) Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int 102:248\u2013260. https:\/\/doi.org\/10.1016\/j.kint.2022.05.012","journal-title":"Kidney Int"},{"key":"5922_CR7","doi-asserted-by":"publisher","first-page":"C106","DOI":"10.1152\/ajpcell.00366.2020","volume":"320","author":"A Sanchez-Navarro","year":"2021","unstructured":"Sanchez-Navarro A, Gonzalez-Soria I, Caldino-Bohn R, Bobadilla NA (2021) An integrative view of Serpins in health and disease: the contribution of SerpinA3. Am J Physiol Cell Physiol 320:C106\u2013C118. https:\/\/doi.org\/10.1152\/ajpcell.00366.2020","journal-title":"Am J Physiol Cell Physiol"},{"key":"5922_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1479-7364-7-22","volume":"7","author":"C Heit","year":"2013","unstructured":"Heit C, Jackson BC, McAndrews M, Wright MW, Thompson DC, Silverman GA, Nebert DW, Vasiliou V (2013) Update of the human and mouse SERPIN gene superfamily. Hum Genomics 7:22. https:\/\/doi.org\/10.1186\/1479-7364-7-22","journal-title":"Hum Genomics"},{"key":"5922_CR9","doi-asserted-by":"publisher","first-page":"e16712","DOI":"10.1371\/journal.pone.0016712","volume":"6","author":"X Liu","year":"2011","unstructured":"Liu X, Lin Z, Zhou T, Zong R, He H, Liu Z, Ma JX, Liu Z, Zhou Y (2011) Anti-angiogenic and anti-inflammatory effects of SERPINA3K on corneal injury. PLoS ONE 6:e16712. https:\/\/doi.org\/10.1371\/journal.pone.0016712","journal-title":"PLoS ONE"},{"key":"5922_CR10","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1167\/iovs.08-2954","volume":"50","author":"B Zhang","year":"2009","unstructured":"Zhang B, Hu Y, Ma JX (2009) Anti-inflammatory and antioxidant effects of SERPINA3K in the retina. Invest Ophthalmol Vis Sci 50:3943\u20133952. https:\/\/doi.org\/10.1167\/iovs.08-2954","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5922_CR11","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1167\/iovs.12-10145","volume":"54","author":"J Hu","year":"2013","unstructured":"Hu J, Zhang Z, Xie H, Chen L, Zhou Y, Chen W, Liu Z (2013) Serine protease inhibitor A3K protects rabbit corneal endothelium from barrier function disruption induced by TNF-alpha. Invest Ophthalmol Vis Sci 54:5400\u20135407. https:\/\/doi.org\/10.1167\/iovs.12-10145","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5922_CR12","doi-asserted-by":"publisher","first-page":"e4077","DOI":"10.1371\/journal.pone.0004077","volume":"3","author":"B Zhang","year":"2008","unstructured":"Zhang B, Ma JX (2008) SERPINA3K prevents oxidative stress induced necrotic cell death by inhibiting calcium overload. PLoS ONE 3:e4077. https:\/\/doi.org\/10.1371\/journal.pone.0004077","journal-title":"PLoS ONE"},{"key":"5922_CR13","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.2337\/db09-1056","volume":"59","author":"B Zhang","year":"2010","unstructured":"Zhang B, Zhou KK, Ma JX (2010) Inhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT\/beta-catenin pathway. Diabetes 59:1809\u20131816. https:\/\/doi.org\/10.2337\/db09-1056","journal-title":"Diabetes"},{"key":"5922_CR14","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1167\/iovs.17-21544","volume":"58","author":"X Zheng","year":"2017","unstructured":"Zheng X, Cui H, Yin Y, Zhang Y, Zong R, Bao X, Ma JX, Liu Z, Zhou Y (2017) Serpina3k ameliorates the corneal oxidative injury induced by 4-hydroxynonenal. Invest Ophthalmol Vis Sci 58:2874\u20132883. https:\/\/doi.org\/10.1167\/iovs.17-21544","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5922_CR15","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.1167\/iovs.12-9729","volume":"53","author":"T Zhou","year":"2012","unstructured":"Zhou T, Zong R, Zhang Z, Zhu C, Pan F, Xiao X, Liu Z, He H, Ma JX, Liu Z et al (2012) SERPINA3K protects against oxidative stress via modulating ROS generation\/degradation and KEAP1-NRF2 pathway in the corneal epithelium. Invest Ophthalmol Vis Sci 53:5033\u20135043. https:\/\/doi.org\/10.1167\/iovs.12-9729","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5922_CR16","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41467-024-55589-w","volume":"16","author":"L Wang","year":"2025","unstructured":"Wang L, Li D, Yao F, Feng S, Tong C, Rao R, Zhong M, Wang X, Feng W, Hu Z et al (2025) Serpina3k lactylation protects from cardiac ischemia reperfusion injury. Nat Commun 16:1012. https:\/\/doi.org\/10.1038\/s41467-024-55589-w","journal-title":"Nat Commun"},{"key":"5922_CR17","doi-asserted-by":"publisher","first-page":"e22190","DOI":"10.1096\/fj.202101912R","volume":"36","author":"A Sanchez-Navarro","year":"2022","unstructured":"Sanchez-Navarro A, Murillo-de-Ozores AR, Perez-Villalva R, Linares N, Carbajal-Contreras H, Flores ME, Gamba G, Castaneda-Bueno M, Bobadilla NA (2022) Transient response of serpinA3 during cellular stress. FASEB J 36:e22190. https:\/\/doi.org\/10.1096\/fj.202101912R","journal-title":"FASEB J"},{"key":"5922_CR18","doi-asserted-by":"publisher","first-page":"979995","DOI":"10.3389\/fimmu.2022.979995","volume":"13","author":"Z Fan","year":"2022","unstructured":"Fan Z, Gao Y, Jiang N, Zhang F, Liu S, Li Q (2022) Immune-related SERPINA3 as a biomarker involved in diabetic nephropathy renal tubular injury. Front Immunol 13:979995. https:\/\/doi.org\/10.3389\/fimmu.2022.979995","journal-title":"Front Immunol"},{"key":"5922_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46601-1","volume":"9","author":"A Sanchez-Navarro","year":"2019","unstructured":"Sanchez-Navarro A, Mejia-Vilet JM, Perez-Villalva R, Carrillo-Perez DL, Marquina-Castillo B, Gamba G, Bobadilla NA (2019) SerpinA3 in the early recognition of acute kidney injury to chronic kidney disease (CKD) transition in the rat and its potentiality in the recognition of patients with CKD. Sci Rep 9:10350. https:\/\/doi.org\/10.1038\/s41598-019-46601-1","journal-title":"Sci Rep"},{"key":"5922_CR20","doi-asserted-by":"publisher","first-page":"F425","DOI":"10.1152\/ajprenal.00099.2022","volume":"323","author":"MA Martinez-Rojas","year":"2022","unstructured":"Martinez-Rojas MA, Sanchez-Navarro A, Mejia-Vilet JM, Perez-Villalva R, Uribe N, Bobadilla NA (2022) Urinary serpin-A3 is an early predictor of clinical response to therapy in patients with proliferative lupus nephritis. Am J Physiol-Renal Physiol 323:F425\u2013F434. https:\/\/doi.org\/10.1152\/ajprenal.00099.2022","journal-title":"Am J Physiol-Renal Physiol"},{"key":"5922_CR21","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1053\/j.gastro.2021.05.008","volume":"161","author":"A Fuchs","year":"2021","unstructured":"Fuchs A, Samovski D, Smith GI, Cifarelli V, Farabi SS, Yoshino J, Pietka T, Chang SW, Ghosh S, Myckatyn TM et al (2021) Associations among adipose tissue Immunology, Inflammation, exosomes and insulin sensitivity in people with obesity and nonalcoholic fatty liver disease. Gastroenterology 161:968\u2013981e912. https:\/\/doi.org\/10.1053\/j.gastro.2021.05.008","journal-title":"Gastroenterology"},{"key":"5922_CR22","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-2739","author":"D Samovski","year":"2025","unstructured":"Samovski D, Smith GI, Palacios H, Pietka T, Fuchs A, Patti GJ, Nawaz A, Kahn CR, Klein S (2025) Effect of marked weight loss on adipose tissue biology in people with obesity and type 2 diabetes. Diabetes Care. https:\/\/doi.org\/10.2337\/dc24-2739","journal-title":"Diabetes Care"},{"key":"5922_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097815","author":"I Gonzalez-Soria","year":"2023","unstructured":"Gonzalez-Soria I, Soto-Valadez AD, Martinez-Rojas MA, Ortega-Trejo JA, Perez-Villalva R, Gamba G, Sanchez-Navarro A, Bobadilla NA (2023) Serpina3k deficiency reduces oxidative stress in acute kidney injury. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24097815","journal-title":"Int J Mol Sci"},{"key":"5922_CR24","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14937","volume":"9","author":"A Sanchez-Navarro","year":"2021","unstructured":"Sanchez-Navarro A, Martinez-Rojas MA, Caldino-Bohn RI, Perez-Villalva R, Zambrano E, Castro-Rodriguez DC, Bobadilla NA (2021) Early triggers of moderately high-fat diet-induced kidney damage. Physiol Rep 9:e14937. https:\/\/doi.org\/10.14814\/phy2.14937","journal-title":"Physiol Rep"},{"key":"5922_CR25","doi-asserted-by":"publisher","first-page":"e0162131","DOI":"10.1371\/journal.pone.0162131","volume":"11","author":"SJ Glastras","year":"2016","unstructured":"Glastras SJ, Chen H, Teh R, McGrath RT, Chen J, Pollock CA, Wong MG, Saad S (2016) Mouse models of diabetes, obesity and related kidney disease. PLoS ONE 11:e0162131. https:\/\/doi.org\/10.1371\/journal.pone.0162131","journal-title":"PLoS ONE"},{"key":"5922_CR26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419. https:\/\/doi.org\/10.1007\/BF00280883","journal-title":"Diabetologia"},{"key":"5922_CR27","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1055\/s-0030-1267205","volume":"42","author":"BM Leijonhufvud","year":"2010","unstructured":"Leijonhufvud BM, Hertel K, Lofgren P (2010) Lipolysis index: evaluation of a new tool for metabolic assessment in epidemiological studies on obesity. Horm Metab Res 42:907\u2013911. https:\/\/doi.org\/10.1055\/s-0030-1267205","journal-title":"Horm Metab Res"},{"key":"5922_CR28","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1023\/b:bile.0000019559.84305.47","volume":"26","author":"MW Pfaffl","year":"2004","unstructured":"Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP (2004) Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: Bestkeeper\u2013excel-based tool using pair-wise correlations. Biotechnol Lett 26:509\u2013515. https:\/\/doi.org\/10.1023\/b:bile.0000019559.84305.47","journal-title":"Biotechnol Lett"},{"key":"5922_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052573","author":"A Sanchez-Navarro","year":"2022","unstructured":"Sanchez-Navarro A, Martinez-Rojas MA, Albarran-Godinez A, Perez-Villalva R, Auwerx J, de la Cruz A, Noriega LG, Rosetti F, Bobadilla NA (2022) Sirtuin 7 deficiency reduces inflammation and tubular damage induced by an episode of acute kidney injury. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23052573","journal-title":"Int J Mol Sci"},{"key":"5922_CR30","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497\u2013509","journal-title":"J Biol Chem"},{"key":"5922_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101257","volume":"53","author":"S Yu","year":"2021","unstructured":"Yu S, Meng S, Xiang M, Ma H (2021) Phosphoenolpyruvate carboxykinase in cell metabolism: roles and mechanisms beyond gluconeogenesis. Mol Metab 53:101257. https:\/\/doi.org\/10.1016\/j.molmet.2021.101257","journal-title":"Mol Metab"},{"key":"5922_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","volume":"29","author":"MF Gregor","year":"2011","unstructured":"Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29:415\u2013445. https:\/\/doi.org\/10.1146\/annurev-immunol-031210-101322","journal-title":"Annu Rev Immunol"},{"key":"5922_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrm2391","volume":"9","author":"A Guilherme","year":"2008","unstructured":"Guilherme A, Virbasius JV, Puri V, Czech MP (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9:367\u2013377. https:\/\/doi.org\/10.1038\/nrm2391","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5922_CR34","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1172\/JCI45887","volume":"121","author":"K Sun","year":"2011","unstructured":"Sun K, Kusminski CM, Scherer PE (2011) Adipose tissue remodeling and obesity. J Clin Invest 121:2094\u20132101. https:\/\/doi.org\/10.1172\/JCI45887","journal-title":"J Clin Invest"},{"key":"5922_CR35","doi-asserted-by":"publisher","first-page":"E1118","DOI":"10.1152\/ajpendo.00435.2007","volume":"293","author":"J Ye","year":"2007","unstructured":"Ye J, Gao Z, Yin J, He Q (2007) Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob\/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293:E1118\u20131128. https:\/\/doi.org\/10.1152\/ajpendo.00435.2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"5922_CR36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","volume":"72","author":"JM Olefsky","year":"2010","unstructured":"Olefsky JM, Glass CK (2010) Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 72:219\u2013246. https:\/\/doi.org\/10.1146\/annurev-physiol-021909-135846","journal-title":"Annu Rev Physiol"},{"key":"5922_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1146\/annurev-physiol-060721-092930","volume":"84","author":"G Marcelin","year":"2022","unstructured":"Marcelin G, Gautier EL, Clement K (2022) Adipose tissue fibrosis in obesity: etiology and challenges. Annu Rev Physiol 84:135\u2013155. https:\/\/doi.org\/10.1146\/annurev-physiol-060721-092930","journal-title":"Annu Rev Physiol"},{"key":"5922_CR38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/BF03347427","volume":"30","author":"M Bahceci","year":"2007","unstructured":"Bahceci M, Gokalp D, Bahceci S, Tuzcu A, Atmaca S, Arikan S (2007) The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? J Endocrinol Invest 30:210\u2013214. https:\/\/doi.org\/10.1007\/BF03347427","journal-title":"J Endocrinol Invest"},{"key":"5922_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98\u2013107. https:\/\/doi.org\/10.1038\/nri2925","journal-title":"Nat Rev Immunol"},{"key":"5922_CR40","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s00125-020-05245-x","volume":"63","author":"N Esser","year":"2020","unstructured":"Esser N, Utzschneider KM, Kahn SE (2020) Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia. Diabetologia 63:2007\u20132021. https:\/\/doi.org\/10.1007\/s00125-020-05245-x","journal-title":"Diabetologia"},{"key":"5922_CR41","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","volume":"132","author":"SE Shoelson","year":"2007","unstructured":"Shoelson SE, Herrero L, Naaz A (2007) Obesity, inflammation, and insulin resistance. Gastroenterology 132:2169\u20132180. https:\/\/doi.org\/10.1053\/j.gastro.2007.03.059","journal-title":"Gastroenterology"},{"key":"5922_CR42","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860\u2013867. https:\/\/doi.org\/10.1038\/nature05485","journal-title":"Nature"},{"key":"5922_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mcna.2012.10.001","volume":"97","author":"AT Reutens","year":"2013","unstructured":"Reutens AT (2013) Epidemiology of diabetic kidney disease. Med Clin North Am 97:1\u201318. https:\/\/doi.org\/10.1016\/j.mcna.2012.10.001","journal-title":"Med Clin North Am"},{"key":"5922_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jprot.2013.03.014","volume":"84","author":"E Takahashi","year":"2013","unstructured":"Takahashi E, Okumura A, Unoki-Kubota H, Hirano H, Kasuga M, Kaburagi Y (2013) Differential proteome analysis of serum proteins associated with the development of type 2 diabetes mellitus in the KK-A(y) mouse model using the iTRAQ technique. J Proteom 84:40\u201351. https:\/\/doi.org\/10.1016\/j.jprot.2013.03.014","journal-title":"J Proteom"},{"key":"5922_CR45","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/jdi.12638","volume":"8","author":"E Takahashi","year":"2017","unstructured":"Takahashi E, Unoki-Kubota H, Shimizu Y, Okamura T, Iwata W, Kajio H, Yamamoto-Honda R, Shiga T, Yamashita S, Tobe K et al (2017) Proteomic analysis of serum biomarkers for prediabetes using the Long-Evans Agouti rat, a spontaneous animal model of type 2 diabetes mellitus. J Diabetes Investig 8:661\u2013671. https:\/\/doi.org\/10.1111\/jdi.12638","journal-title":"J Diabetes Investig"},{"key":"5922_CR46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1126\/science.180605","volume":"193","author":"AA Like","year":"1976","unstructured":"Like AA, Rossini AA (1976) Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193:415\u2013417. https:\/\/doi.org\/10.1126\/science.180605","journal-title":"Science"},{"key":"5922_CR47","doi-asserted-by":"publisher","first-page":"537","DOI":"10.33549\/physiolres.930111","volume":"50","author":"T Szkudelski","year":"2001","unstructured":"Szkudelski T (2001) The mechanism of Alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:537\u2013546","journal-title":"Physiol Res"},{"key":"5922_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1681\/ASN.2005070757","volume":"17","author":"M Nangaku","year":"2006","unstructured":"Nangaku M (2006) Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 17:17\u201325. https:\/\/doi.org\/10.1681\/ASN.2005070757","journal-title":"J Am Soc Nephrol"},{"key":"5922_CR49","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/hy09t1.094234","volume":"38","author":"SA Mezzano","year":"2001","unstructured":"Mezzano SA, Ruiz-Ortega M, Egido J (2001) Angiotensin II and renal fibrosis. Hypertension 38:635\u2013638. https:\/\/doi.org\/10.1161\/hy09t1.094234","journal-title":"Hypertension"},{"key":"5922_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/sj.ki.5000054","volume":"69","author":"Y Liu","year":"2006","unstructured":"Liu Y (2006) Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 69:213\u2013217. https:\/\/doi.org\/10.1038\/sj.ki.5000054","journal-title":"Kidney Int"},{"key":"5922_CR51","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","volume":"13","author":"Y Li","year":"2011","unstructured":"Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Park O, Luo Z, Lefai E, Shyy JY et al (2011) AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab 13:376\u2013388. https:\/\/doi.org\/10.1016\/j.cmet.2011.03.009","journal-title":"Cell Metab"},{"key":"5922_CR52","doi-asserted-by":"publisher","first-page":"6508","DOI":"10.1128\/MCB.20.17.6508-6517.2000","volume":"20","author":"P She","year":"2000","unstructured":"She P, Shiota M, Shelton KD, Chalkley R, Postic C, Magnuson MA (2000) Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism. Mol Cell Biol 20:6508\u20136517. https:\/\/doi.org\/10.1128\/MCB.20.17.6508-6517.2000","journal-title":"Mol Cell Biol"},{"key":"5922_CR53","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.biochi.2022.08.021","volume":"204","author":"D Calderon-DuPont","year":"2023","unstructured":"Calderon-DuPont D, Torre-Villalvazo I, Diaz-Villasenor A (2023) Is insulin resistance tissue-dependent and substrate-specific? The role of white adipose tissue and skeletal muscle. Biochimie 204:48\u201368. https:\/\/doi.org\/10.1016\/j.biochi.2022.08.021","journal-title":"Biochimie"},{"key":"5922_CR54","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cmet.2024.04.006","volume":"36","author":"T Bo","year":"2024","unstructured":"Bo T, Gao L, Yao Z, Shao S, Wang X, Proud CG, Zhao J (2024) Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease. Cell Metab 36:947\u2013968. https:\/\/doi.org\/10.1016\/j.cmet.2024.04.006","journal-title":"Cell Metab"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05922-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05922-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05922-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T05:01:05Z","timestamp":1764651665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05922-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5922"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05922-3","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no financial or personal relationships with individuals or organizations that could inappropriately influence or bias our work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interest"}}],"article-number":"434"}}